Skip to main content
logo
Novogene Co., Ltd. (SHA:688315)
China flag China · Delayed Price · Currency is CNY
13.88
+0.66 (4.99%)
Jul 15, 2026, 3:00 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Life Science Basic Research Service
791.82M
655.75M
678.18M552.25M356.63M
Life Science Basic Research Service Growth
-
-
22.80%54.85%43.84%
Medical Research and Technical Services
289.20M
273.10M
306.22M272.44M234.89M
Medical Research and Technical Services Growth
-
-
12.40%15.99%72.97%
Sequencing Platform Services
1.06B
704.33M
384.89M203.76M141.74M
Sequencing Platform Services Growth
-
-
88.89%43.76%89.61%
Others
58.99M
230.49M
165.53M24.22M5.95M
Others Growth
-
-
583.39%306.81%-
Total
2.20B
1.86B
1.53B1.05B739.21M
Total Growth
-
-
45.80%42.41%61.23%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Mainland China
1.11B
1.20B
1.06B738.25M577.01M
Mainland China Growth
-
-
44.21%27.94%-
Hong Kong, Macao, Taiwan and Overseas
1.09B
665.79M
---
America
-
-
216.94M120.91M67.85M
America Growth
-
-
79.43%78.20%-
Europe
-
-
96.66M76.71M14.59M
Europe Growth
-
-
26.01%425.83%-
Singapore
-
-
53.52M49.31M21.22M
Singapore Growth
-
-
8.54%132.40%-
Asia-Pacific (Except Singapore and China)
-
-
103.09M67.50M58.54M
Asia-Pacific (Except Singapore and China) Growth
-
-
52.72%15.31%-
Total
2.20B
1.86B
1.53B1.05B739.21M
Total Growth
-
-
45.80%42.41%61.23%